Alonso Guzmán

Alonso Guzmán has worked in the pharmaceutical industry since 2007. Alonso began their career as the CEO and President of CONSULTANTCR, LLC., where they provided regulatory operations and regulatory affairs services to clients worldwide. In 2010, they joined WMackin & Associates as a Consultant: Head of Regulatory Affairs Operations, Publishing and Submission Management, where they were responsible for managing the publishing, archiving, and dossier management functions. In 2016, they joined Global Regulatory Partners-LLC as a Consultant: Head of Regulatory Affairs Operations, Publishing, and Submission Management, and in 2018 they joined AKEBIA as a Consultant, Regulatory Operations. In 2021, they became a Consultant: Regulatory Operation, US Submission Management for Tanvex Biopharma USA, Inc. and in 2022 they took on the same role for Hillhurst Biopharmaceuticals, Inc., PapiVax Biotech, and AOBiome Therapeutics, Inc. Alonso is currently a Consultant: Regulatory Operations, Submission Management, and Veeva RIM Business Administrator for Rhythm Pharmaceuticals Inc. and Mersana Therapeutics.

Alonso Guzmán attended Harvard Extension School from 1994 to 1996, and also attended Cambridge College.